Complications, morbidity and mortality of nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is influenced by the epidemics of obesity and type 2 diabetes mellitus (T2DM) and the prevalence of these conditions is not expected to decrease in the forthcoming decades. Consequently, the burden of NAFLD-related liver complications (non-alcoholic steatohepatitis [NASH], cirrhosis and hepatocellular carcinoma) and the need for life-saving liver transplantation are also expected to increase further in the near future. It is predicted that NAFLD will soon become the most important indication for liver transplantation. A large body of clinical evidence indicates that NAFLD is associated not only with increased liver-related morbidity and mortality, but also with an increased risk of developing other important extra-hepatic diseases, such as cardiovascular disease (that is the predominant cause of death in patients with NAFLD), extra-hepatic cancers (mainly colorectal cancers), T2DM and chronic kidney disease. Thus, NAFLD creates a considerable health and economic burden worldwide and often results in poor quality of life. This narrative review provides an overview of the current literature on main complications, morbidity and mortality of this common and burdensome liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationMechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationGlobal perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Self-citationNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Self-citationObesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Self-citationMcPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Adams, L. A., Sanderson, S., Lindor, K. D., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 911
Stefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.034 · Cited by 806
Younossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V. W., Negro, F., Yilmaz, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.057 · Cited by 806
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Overproduction of large VLDL particles is driven by increased liver fat content in man
Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0125-z · Cited by 690
Mittal, S., El-Serag, H. B., Sada, Y. H., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.019 · Cited by 648
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G. (2018) · Diabetes Care · doi:10.2337/dc17-1902 · Cited by 624
Self-citationThe Natural Course of Non-Alcoholic Fatty Liver Disease
Calzadilla Bertot, L., & Adams, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050774 · Cited by 620
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Self-citationKowdley, K. V., Belt, P., Wilson, L. A., Yeh, M. M., Neuschwander–Tetri, B. A., Chalasani, N., Sanyal, A. J., & Nelson, J. E. (2012) · Hepatology · doi:10.1002/hep.24706 · Cited by 543
Pais, R., Charlotte, F., Fedchuk, L., Bedossa, P., Lebray, P., Poynard, T., & Ratziu, V. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.027 · Cited by 522
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Self-citationRich, N. E., Oji, S., Mufti, A. R., Browning, J. D., Parikh, N. D., Odewole, M., Mayo, H., & Singal, A. G. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.041 · Cited by 486
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Heritability of Nonalcoholic Fatty Liver Disease
Schwimmer, J. B., Celedon, M. A., Lavine, J. E., Salem, R., Campbell, N., Schork, N. J., Shiehmorteza, M., Yokoo, T., Chavez, A., Middleton, M. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.050 · Cited by 466
Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J. M., Saracco, G., Adams, L. A., Charatcharoenwitthaya, P., Topping, J. H., Bugianesi, E., et al. (2011) · Hepatology · doi:10.1002/hep.24491 · Cited by 450
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationNonalcoholic Fatty Liver Disease and the Heart
Stahl, E. P., Dhindsa, D. S., Lee, S. K., Sandesara, P. B., Chalasani, N. P., & Sperling, L. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.050 · Cited by 439
Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease
Schwimmer, J. B., Pardee, P. E., Lavine, J. E., Blumkin, A. K., & Cook, S. (2008) · Circulation · doi:10.1161/circulationaha.107.739920 · Cited by 402
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
Self-citationNon-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Sanyal, A. J., Harrison, S. A., Ratziu, V., Abdelmalek, M. F., Diehl, A. M., Caldwell, S., Shiffman, M. L., Aguilar Schall, R., Jia, C., McColgan, B., et al. (2019) · Hepatology · doi:10.1002/hep.30664 · Cited by 390
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Allen, A. M., Therneau, T. M., Larson, J. J., Coward, A., Somers, V. K., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.29546 · Cited by 370
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Mantovani, A., Zaza, G., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G. (2018) · Metabolism · doi:10.1016/j.metabol.2017.11.003 · Cited by 348
Self-citationAssociation between non-alcoholic fatty liver disease and cancer incidence rate
Kim, G.-A., Lee, H. C., Choe, J., Kim, M.-J., Lee, M. J., Chang, H.-S., Bae, I. Y., Kim, H.-K., An, J., Shim, J. H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.012 · Cited by 331
Kanwal, F., Kramer, J. R., Li, L., Dai, J., Natarajan, Y., Yu, X., Asch, S. M., & El‐Serag, H. B. (2020) · Hepatology · doi:10.1002/hep.31014 · Cited by 319
Allen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J., & Therneau, T. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.018 · Cited by 312
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Anstee, Q. M., Mantovani, A., Tilg, H., & Targher, G. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0010-0 · Cited by 310
Self-citationNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Targher, G., & Byrne, C. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.16 · Cited by 309
Self-citationStepanova, M., Rafiq, N., Makhlouf, H., Agrawal, R., Kaur, I., Younoszai, Z., McCullough, A., Goodman, Z., & Younossi, Z. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2743-5 · Cited by 301
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
Alexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., et al. (2019) · BMJ · doi:10.1136/bmj.l5367 · Cited by 254
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S., Pirola, C. J., & Targher, G. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236
Self-citationLiver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes
Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., Younossi, Z. M., Harrison, S. A., & Ahmed, A. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4684-x · Cited by 234
Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
Paik, J. M., Henry, L., De Avila, L., Younossi, E., Racila, A., & Younossi, Z. M. (2019) · Hepatology Communications · doi:10.1002/hep4.1419 · Cited by 225
Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Newton, K. P., Hou, J., Crimmins, N. A., Lavine, J. E., Barlow, S. E., Xanthakos, S. A., Africa, J., Behling, C., Donithan, M., Clark, J. M., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.1971 · Cited by 224
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Self-citationGenetic predisposition in nonalcoholic fatty liver disease
Sookoian, S., & Pirola, C. J. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0109 · Cited by 213
Treeprasertsuk, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1219 · Cited by 200
Liu, Y., Zhong, G.-C., Tan, H.-Y., Hao, F.-B., & Hu, J.-J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47687-3 · Cited by 176
Yamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 172
Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
The Epidemiology of Hepatocellular Carcinoma in the USA
Kim, H.-S., & El-Serag, H. B. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0681-x · Cited by 159
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 156
Lee, S. B., Park, G., Lee, J., Lee, B. U., Park, J. H., Kim, B. G., Jung, S. W., Jeong, I. D., Bang, S. J., Shin, J. W., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.012 · Cited by 155
Nonalcoholic Fatty Liver Disease in Children
Mann, J., Valenti, L., Scorletti, E., Byrne, C., & Nobili, V. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1627456 · Cited by 152
Self-citationNasr, P., Ignatova, S., Kechagias, S., & Ekstedt, M. (2018) · Hepatology Communications · doi:10.1002/hep4.1134 · Cited by 151
Loomba, R., & Adams, L. A. (2019) · Hepatology · doi:10.1002/hep.30946 · Cited by 150
Golabi, P., Paik, J. M., Reddy, R., Bugianesi, E., Trimble, G., & Younossi, Z. M. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0972-6 · Cited by 139
Wild, S. H., Walker, J. J., Morling, J. R., McAllister, D. A., Colhoun, H. M., Farran, B., McGurnaghan, S., McCrimmon, R., Read, S. H., Sattar, N., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1590 · Cited by 138
Self-citationHagström, H., Nasr, P., Ekstedt, M., Stål, P., Hultcrantz, R., & Kechagias, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.11.030 · Cited by 132
Mantovani, A., Dauriz, M., Sandri, D., Bonapace, S., Zoppini, G., Tilg, H., Byrne, C. D., & Targher, G. (2019) · Liver International · doi:10.1111/liv.14044 · Cited by 132
Self-citationPersistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 120
Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112841 · Cited by 120
Self-citationImpact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany
Labenz, C., Huber, Y., Michel, M. S., Nagel, M. C., Galle, P. R., Kostev, K., & Schattenberg, J. M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05986-9 · Cited by 117
Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Sinn, D. H., Kang, D., Chang, Y., Ryu, S., Cho, S. J., Paik, S. W., Song, Y. B., Pastor‐Barriuso, R., Guallar, E., Cho, J., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14856 · Cited by 116
Mantovani, A., Dauriz, M., Byrne, C. D., Lonardo, A., Zoppini, G., Bonora, E., & Targher, G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.06.004 · Cited by 110
Self-citationNonalcoholic Fatty Liver Disease and Incident Cardiac Events
Zeb, I., Li, D., Budoff, M. J., Katz, R., Lloyd‐Jones, D. M., Agatston, A. A., Blumenthal, R. S., Blaha, M. J., Blankstein, R., Carr, J. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.070 · Cited by 109
Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
Byrne, C. D., Patel, J., Scorletti, E., & Targher, G. (2018) · BMJ · doi:10.1136/bmj.k2734 · Cited by 108
Self-citationLee, Y. I., Lim, Y., & Park, H. S. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06816.x · Cited by 97
Targher, G., Marchesini, G., & Byrne, C. D. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.002 · Cited by 97
Self-citationNoninvasive fatty liver markers predict liver disease mortality in the U.S. population
Unalp‐Arida, A., & Ruhl, C. E. (2016) · Hepatology · doi:10.1002/hep.28390 · Cited by 96
Byrne, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03732.x · Cited by 95
Self-citationSun, D., Zheng, K. I., Xu, G., Ma, H., Zhang, H., Pan, X., Zhu, P., Wang, X., Targher, G., Byrne, C. D., et al. (2019) · Liver International · doi:10.1111/liv.14251 · Cited by 87
Self-citationEstrogens and female liver health
Chen, K. L., & Madak‐Erdogan, Z. (2017) · Steroids · doi:10.1016/j.steroids.2017.10.015 · Cited by 86
Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease
Chinnadurai, R., Ritchie, J. P., Green, D., & Kalra, P. A. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx381 · Cited by 84
Keskin, M., Hayıroğlu, M. İ., Uzun, A. O., Güvenç, T. S., Şahin, S., & Kozan, Ö. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.107 · Cited by 83
Huang, K. ‐., Leu, H. ‐., Wang, Y. ‐., Luo, J. ‐., Lin, H. ‐., Lee, F. ‐., Chan, W. ‐., Lin, J. ‐., & Chang, F. ‐. (2013) · Colorectal Disease · doi:10.1111/codi.12172 · Cited by 80
Álvarez, C. S., Graubard, B. I., Thistle, J. E., Petrick, J. L., & McGlynn, K. A. (2019) · Hepatology · doi:10.1002/hep.31040 · Cited by 77
Sung, K., Cha, S.-C., Sung, J.-W., So, M.-S., & Byrne, C. D. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.07.005 · Cited by 74
Self-citationHwang, Y., Ahn, H. Y., Park, S., & Park, C. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.11.026 · Cited by 73
Nobili, V., Mantovani, A., Cianfarani, S., Alisi, A., Mosca, A., Sartorelli, M. R., Maffeis, C., Loomba, R. S., Byrne, C. D., & Targher, G. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.023 · Cited by 72
Self-citationGómez, E. V., Bertot, L. C., Friedman, S. L., Gra‐Oramas, B., Gonzalez‐Fabian, L., Villa-Jiménez, O. M., del Vallín, S. L., Diago, M., Adams, L. A., Romero‐Gómez, M., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13860 · Cited by 71
Pediatric Nonalcoholic Fatty Liver Disease
Bozic, M. A., Subbarao, G. C., & Molleston, J. P. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533613489153 · Cited by 70
Targher, G., Mantovani, A., Alisi, A., Mosca, A., Panera, N., Byrne, C. D., & Nobili, V. (2019) · Hepatology · doi:10.1002/hep.30625 · Cited by 67
Self-citationHolmer, M., Melum, E., Isoniemi, H., Ericzon, B., Castedal, M., Nordin, A., Aagaard Schultz, N., Rasmussen, A., Line, P., Stål, P., et al. (2018) · Liver International · doi:10.1111/liv.13751 · Cited by 66
Nass, K. J., van den Berg, E. H., Faber, K. N., Schreuder, T. C. M. A., Blokzijl, H., & Dullaart, R. P. F. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.004 · Cited by 64
Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women
Kwak, M., Yim, J. Y., Yi, A., Chung, G. E., Yang, J. I., Kim, D., Kim, J. S., & Noh, D. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.12.024 · Cited by 64
Goossens, N., Hoshida, Y., Song, W. M., Jung, M., Morel, P., Nakagawa, S., Zhang, B., Frossard, J.-L., Spahr, L., Friedman, S. L., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.10.010 · Cited by 61
The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
Pacifico, L., Bonci, E., Andreoli, G. M., Martino, M. D., Gallozzi, A., Luca, E. D., & Chiesa, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081218 · Cited by 60
Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
Choudhary, N. S., & Duseja, A. K. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.02.005 · Cited by 56
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Imai, N., Kobayashi, M., Sezaki, H., Matsumoto, N., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00915.x · Cited by 53
Liver Fat and Cardiometabolic Risk Factors Among School‐Age Children
Geurtsen, M. L., Santos, S., Felix, J. F., Duijts, L., Vernooij, M. W., Gaillard, R., & Jaddoe, V. W. V. (2019) · Hepatology · doi:10.1002/hep.31018 · Cited by 53
Calzadilla‐Bertot, L., Jeffrey, G. P., Jacques, B., McCaughan, G., Crawford, M., Angus, P., Jones, R., Gane, E., Munn, S., Macdonald, G., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25361 · Cited by 52
Valbusa, F., Agnoletti, D., Scala, L., Grillo, C., Arduini, P., Bonapace, S., Calabria, S., Scaturro, G., Mantovani, A., Zoppini, G., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.129 · Cited by 51
Self-citationNonalcoholic fatty liver disease and the heart in children and adolescents.
Pacifico, L., Chiesa, C., Anania, C., Merulis, A. D., Osborn, J. F., Romaggioli, S., & Gaudio, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9055 · Cited by 49
Yang, J. D., Mohammed, H. A., Harmsen, W. S., Enders, F., Gores, G. J., & Roberts, L. R. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000810 · Cited by 49
Marzuillo, P., Sessa, A. D., Guarino, S., Capalbo, D., Umano, G. R., Pedullà, M., Manna, A. L., Cirillo, G., & del Giudice, E. M. (2019) · Pediatric Obesity · doi:10.1111/ijpo.12539 · Cited by 49
Liver fat scores predict liver disease mortality in the United States population
Ünalp–Arida, A., & Ruhl, C. E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14967 · Cited by 46
Choi, Y. J., Lee, D. H., Han, K.-D., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201308 · Cited by 44
Mantovani, A., Zusi, C., Sani, E., Colecchia, A., Lippi, G., Zaza, G., Valenti, L. V. C., Byrne, C. D., Maffeis, C., Bonora, E., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.011 · Cited by 44
Self-citationCostanzo, A. D., Pacifico, L., D’Erasmo, L., Polito, L., Martino, M. D., Perla, F. M., Iezzi, L., Chiesa, C., & Arca, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184444 · Cited by 41
A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths
Pacifico, L., Perla, F. M., Roggini, M., Andreoli, G. M., D’Avanzo, M., & Chiesa, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060868 · Cited by 40
Hamaguchi, M., Hashimoto, Y., Obora, A., Kojima, T., & Fukui, M. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000295 · Cited by 39
Relationship between Non-Alcoholic Fatty Liver Disease and Breast Cancer.
Nseir, W., Zuhair, A.-R., Tsipis, A., Mograbi, J., & Mahamid, M. (2017) · PubMed · Cited by 38
Labenz, C., Prochaska, J. H., Huber, Y., Nagel, M., Straub, B. K., Wild, P. S., Galle, P. R., & Schattenberg, J. M. (2019) · Hepatology Communications · doi:10.1002/hep4.1428 · Cited by 37
Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease
Manco, M., Ciampalini, P., Vito, R. D., Vania, A., Cappa, M., & Nobili, V. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1134-9 · Cited by 36
Xun, Y., Guo, J., Lou, G., Jiang, Y., Zhuang, Z., Zhu, M., Luo, Y., Ma, X., Liu, J., Bian, D., et al. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12260 · Cited by 36
Yang, Y. J., Bang, C. S., Shin, S. P., & Baik, G. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182014 · Cited by 36
Önnerhag, K., Dreja, K., Nilsson, P. M., & Lindgren, S. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.02.004 · Cited by 36
Non-alcoholic fatty liver disease and colorectal cancer survival
Wu, K., Zhai, M. Z., Weltzien, E. K., Feliciano, E. M. C., Meyerhardt, J. A., Giovannucci, E. L., & Caan, B. J. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1095-z · Cited by 32
Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.
Jepsen, P., Vilstrup, H., Møller, J. K., et al. (2004) · PubMed · Cited by 29
Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence
Choi, W., Lee, J., Yoon, J., Kwak, C. H., Lee, Y. J., Cho, Y. Y., Lee, Y. B., Yu, S. J., Kim, Y. J., Kim, H. H., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0036 · Cited by 25
Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease
Fleet, S. E., Lefkowitch, J. H., & Lavine, J. E. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.002 · Cited by 22
Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.08.003 · Cited by 19
Chen, Z., Dong, X., Huang, Q., Hong, W., Wu, W., Wu, J.-S., & Pan, S. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1461-z · Cited by 18
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?
Marchesini, G., Petroni, M. L., & Cortez‐Pinto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.020 · Cited by 18
Nonalcoholic fatty liver disease: implications for cardiovascular risk
Dinani, A. M., & Sanyal, A. J. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000126 · Cited by 17
Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study
Mahady, S. E., Wong, G., Turner, R. M., Mitchell, P., Macaskill, P., Craig, J. C., & George, J. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000622 · Cited by 15
Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort
Olubamwo, O., Virtanen, J. K., Pihlajamäki, J., & Tuomainen, T. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000219 · Cited by 12
Fatty liver and mortality: a cohort population study in South Italy
Caruso, M. G., Veronese, N., Notarnicola, M., Cisternino, A. M., Reddavide, R., Inguaggiato, R., Guerra, V., Donghia, R., Logroscino, A. F., Rotolo, O., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027379 · Cited by 9
Pediatric Nonalcoholic Fatty Liver Disease
D’Adamo, E., Loredana, M., de, T., Chiavaroli, V., Giannini, C., Chiarelli, F., & Moh, A. (2013) · InTech eBooks · doi:10.5772/53463 · Cited by 7
Cited by
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Self-citationTargher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 827
Self-citationMantovani, A., Csermely, A., Petracca, G., Beatrice, G., Corey, K. E., Simon, T. G., Byrne, C. D., & Targher, G. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00308-3 · Cited by 674
Self-citationTargher, G., Tilg, H., & Byrne, C. D. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00020-0 · Cited by 586
Self-citationDysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 554
Metadata
- Authors
- Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 111
- Pages
- 154170
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W3004139071
- Cited by
- 553
- References
- 152
- FWCI
- 48.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.